glidobactin A

structure given in first source; isolated from polyangium brachysporum & Pseudomonas

Also Known As:

cepafungin II; 2,4-Dodecadienamide, N-(2-hydroxy-1-(((10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl)amino)carbonyl)propyl)-, (5S-(3E,5R*,8R*(1R*(2E,4E),2S*),10R*))-

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - glidobactin A: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - glidobactin A: 1

Experts

1.	Archer, Crystal R: 1 article (07/2010)
2.	Bachmann, André S: 1 article (07/2010)
3.	Clerc, Jérôme: 1 article (07/2010)
4.	Dudler, Robert: 1 article (07/2010)
5.	Kaiser, Markus: 1 article (07/2010)
6.	Koomoa, Dana-Lynn T: 1 article (07/2010)
7.	Mitsunaga, Erin M: 1 article (07/2010)
8.	Schellenberg, Barbara: 1 article (07/2010)
9.	Shimizu, Mariko: 1 article (07/2010)

Related Diseases

1.	Ovarian Neoplasms (Ovarian Cancer) 07/15/2010 - "In this study, we examined the effects of syringolin A (SylA) and glidobactin A (GlbA) as well as two synthetic SylA-analogs (SylA-PEG and SylA-LIP) in human neuroblastoma (SK-N-SH), human multiple myeloma (MM1.S, MM1.RL, and U266), and human ovarian cancer (SKOV-3) cells. "
2.	Neuroblastoma 07/15/2010 - "In this study, we examined the effects of syringolin A (SylA) and glidobactin A (GlbA) as well as two synthetic SylA-analogs (SylA-PEG and SylA-LIP) in human neuroblastoma (SK-N-SH), human multiple myeloma (MM1.S, MM1.RL, and U266), and human ovarian cancer (SKOV-3) cells. "
3.	Multiple Myeloma 07/15/2010 - "In this study, we examined the effects of syringolin A (SylA) and glidobactin A (GlbA) as well as two synthetic SylA-analogs (SylA-PEG and SylA-LIP) in human neuroblastoma (SK-N-SH), human multiple myeloma (MM1.S, MM1.RL, and U266), and human ovarian cancer (SKOV-3) cells. "

Related Drugs and Biologics

1.	syringolin A